In addition, levels of proNGF, as well as MMP-1, MMP-3, and MMP-9 activity were found elevated at AD asymptomatic stages in the plasma from a cohort of clinically characterized DS individuals. The gene discussed is MMP9; the disease is Alzheimer disease.